The global small-molecule injectable market is anticipated to increase dramatically, from an estimated USD 65.10 billion in 2023 to a projected USD 131.70 billion by 2033. The market is anticipated to rise at a Compound Annual Growth Rate (CAGR) of 7.3% during the course of the projection period, demonstrating robust growth and rising demand for injectable …
Tag Archives: Small-Molecule Injectable Market
Global Small-Molecule Injectable Market Poised for Growth, Predicted to Reach US$ 131.70 Billion by 2033 at a 7.3% CAGR
The global small-molecule injectable market is expected to grow significantly, reaching a projected valuation of US$ 131.70 billion by 2033 from an estimated US$ 65.10 billion in 2023. Over the course of the projection period, the market is expected to acquire a Compound Annual Growth Rate (CAGR) of 7.3%, indicating strong growth and increased demand for injectable …
Small-Molecule Injectable Market Envisions a Striking Reach of US$ 131.70 Billion by 2033-FMI Projection
Small-molecule injectables, comprising a diverse range of pharmaceuticals with low molecular weight, are gaining prominence for their efficacy and versatility in treating various medical conditions. This market’s expansion is fueled by factors such as the rising prevalence of chronic diseases, advancements in drug development, and the increasing demand for targeted therapeutic interventions. The convenience of …
Small-Molecule Injectable Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031
The global small-molecule injectable market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted …